PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain. www.psychedelicstoday.com

Episode metadata supplied by the publisher feed · Published Aug 26, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain

0:00 1:18:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Psychedelics Today?

This episode is 1 hour and 18 minutes long.

When was this Psychedelics Today episode published?

This episode was published on August 26, 2022.

Can I download this Psychedelics Today episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!